Valion Bio (VBIO) Change in Working Capital (2025)
Valion Bio (VBIO) posted Change in Working Capital of $2000.0 for Q1 2025.
Powered by 
Analysis
Valion Bio (VBIO) Change in Working Capital (2025) Analysis & Trends
Valion Bio has reported Change in Working Capital for 1 years, with the latest figure at $2000.0 in Q1 2025.
- On a quarterly basis, Change in Working Capital changed N/A year-over-year to $2000.0 in Q1 2025; TTM through Jun 2025 was $2000.0, a N/A change from a year earlier, with the FY2024 full-year figure at -$34000.0, changed N/A from the prior year.
- Change in Working Capital was $2000.0 for Q1 2025 at Valion Bio.
- The five-year high for Change in Working Capital was $2000.0 in Q1 2025, with the low at $2000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Working Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Valion Bio | 298,792.01 | -1.90 Mn | -45,000.00 | - |